48 results on '"Merino Argumánez C"'
Search Results
2. Desenmascarando la polimialgia reumática, papel de la Medicina Nuclear
3. AB1474 NINTEDANIB IN AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASE: REAL-LIFE EFFECTIVENESS, SAFETY AND TOLERANCE IN A SPANISH MULTICENTER STUDY
4. POS0444 ARTIFICIAL INTELLIGENCE VERSUS RHEUMATOLOGIST IN DECISION MAKING IN THE TREATMENT OF RHEUMATOID ARTHRITIS. DO WE THINK ALIKE?
5. AB1536 MYCOPHENOLATE MOFETIL VERSUS RITUXIMAB IN THE TREATMENT OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES
6. AB1483 NINTEDANIB IN PROGRESSIVE PULMONARY FIBROSIS. COMPARING SUBGROUPS IN CLINICAL PRACTICE. EXPERIENCE OF PULMONOLOGISTS AND RHEUMATOLOGISTS
7. AB0797 DIAGNOSTIC PROTEIN BIOMARKERS IN SJÖGREN´S SYNDROME
8. AB0038 “RHEUMATOLOGIC” CLINICAL PROFILE OF VEXAS SYNDROME: RESULTS FROM A MULTI-INSTITUTIONAL SPANISH SURVEY
9. POS0363 CHALLENGES IN RECOGNIZING VEXAS SYNDROME: DELAYED DIAGNOSIS, MISDIAGNOSIS, AND SPECIFIC GENE MUTATIONS ASSOCIATIONS
10. AB0683 USEFULNESS OF A MONOGRAPHIC CONSULTATION RHEUMATOLOGY - PNEUMOLOGY
11. POS0643 RITUXIMAB-ASSOCIATED HYPOGAMMAGLOBULINEMIA IN PATIENTS WITH RHEUMATIC DISEASES: A MULTICENTER RETROSPECTIVE OBSERVATIONAL STUDY
12. AB1833-HPR STUDY OF THE DEMAND FOR REFERRALS FROM PRIMARY CARE TO THE RHEUMATOLOGY DEPARTMENT OF A TERTIARY HOSPITAL
13. POS0263 PREVALENCE OF OCCIPITAL PROTUBERANCE ENTHESOPHYTE IN NON-INFLAMMATORY AND INFLAMMATORY RHEUMATIC DISEASES: SANZ SIGN
14. AB0951 EFFICACY AND SAFETY OF UPADACITINIB IN ANKYLOSING SPONDYLITIS. REAL WORLD DATA
15. AB0128 DIFFERENTIAL EXPRESSION OF PROTEINS IN PATIENTS WITH SUSPECTED SJÖGREN’S SYNDROME
16. AB0868 IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYOPATHY
17. AB1516 APREMILAST FOR TREATMENT OF ORAL APHTOSIS: REAL-WORD DATA MULTICENTER STUDY
18. AB0742 STEROID-SPARING EFFECT OF METHOTREXATE IN PATIENTS WITH STEROID-RESISTANT POLYMYALGIA RHEUMATICA: MULTICENTER RETROSPECTIVE OBSERVATIONAL STUDY
19. POS0903 ASSOCIATION STUDY BETWEEN ANTI-TIF 1γ ANTIBODY AND DEVELOPMENT OF NEOPLASIA IN THREE TERTIARY HOSPITALS.
20. AB0802 PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE IN RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS, AND PSORIATIC ARTHRITIS.
21. POS0907 ASSOCIATION BETWEEN DISEASE ACTIVITY AND DAMAGE IN IDIOPATHIC INFLAMMATORY MYOPATHIES. DIFFERENCES BETWEEN INCIDENT AND PREVALENT CASES
22. AB0572 USEFULNESS OF MINOR SALIVARY GLAND BIOPSY IN THE DIAGNOSIS OF PATIENTS WITH SUSPECTED PRIMARY SJÖGREN’S SYNDROME
23. AB0430 EFFECTIVENESS OF RITUXIMAB TREATMENT IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME.
24. AB1345 PREDICTIVE MODEL FOR THE DIAGNOSIS OF PSORIATIC ARTHRITIS IN DERMATOLOGY REFERRALS ACCORDING TO PURE-4 SCALE
25. AB1396 MULTICENTER QUALITATIVE STUDY ON THE EXPERIENCE OF USE OF BIOLOGIC AND TARGETED SYNTHETIC DISEASE-MODIFYING DRUGS IN PATIENTS WITH RHEUMATIC DISEASES. WHAT DO OUR PATIENTS THINK?
26. AB0462 CORRELATION BETWEEN SAXON TEST AND UNSTIMULATED SALIVARY FLOW RATE IN PATIENTS WITH SUSPECTED SJÖGREN´S SYNDROME
27. POS1548-HPR USEFULNESS OF AN ELECTRONIC CONSULTATION SYSTEM BETWEEN PRIMARY CARE HEALTH CENTERS AND RHEUMATOLOGY DEPARTMENT OF A TERTIARY HOSPITAL
28. SAT0386 USEFULNESS OF THE FECAL CALPROTECTIN AS SCREENING TOOL FOR INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH SPONDYLOARTHRITIS AND NO DIGESTIVE SYMPTOMS
29. SAT0407 Mycobacterial infections in a rheumatology unit of a tertiary hospital
30. AB0876 Correlation between faecal calprotectin levels and tobacco use in patients with spondyloarthritis and without previous diagnosis of inflammatory bowel disease
31. FRI0190 Relationship between faecal calprotectin, hlab-27 and acute phase reactants in patients with spondyloarthritis without prior diagnosis of inflammatory bowel disease
32. La hidroxicloroquina, un fármaco potencialmente letal
33. Hydroxychloroquine, a potentially lethal drug
34. STUDY OF THE DEMAND FOR REFERRALS FROM PRIMARY CARE TO THE RHEUMATOLOGY DEPARTMENT OF A TERTIARY HOSPITAL.
35. EFFICACY AND SAFETY OF UPADACITINIB IN ANKYLOSING SPONDYLITIS. REAL WORLD DATA.
36. MMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYOPATHY.
37. APREMILAST FOR TREATMENT OF ORAL APHTOSIS: REAL-WORD DATA MULTICENTER STUDY.
38. STEROID-SPARING EFFECT OF METHOTREXATE IN PATIENTS WITH STEROID-RESISTANT POLYMYALGIA RHEUMATICA: MULTICENTER RETROSPECTIVE OBSERVATIONAL STUDY.
39. USEFULNESS OF A MONOGRAPHIC CONSULTATION RHEUMATOLOGY - PNEUMOLOGY.
40. PROFESSIONAL COUNTRY-WIDE SURVEY ON CLINICAL DECISION-MAKING IN THE TREATMENT OF RHEUMATOID ARTHRITIS.
41. DIFFERENTIAL EXPRESSION OF PROTEINS IN PATIENTS WITH SUSPECTED SJÖGREN'S SYNDROME.
42. CORRELATION BETWEEN SAXON TEST AND UNSTIMULATED SALIVARY FLOW RATE IN PATIENTS WITH SUSPECTED SJÖGREN'S SYNDROME.
43. Síndrome de platipnea-ortodeoxia
44. Recommendations by the Spanish Society of Rheumatology on the management of patients with fibromyalgia. Part II.
45. Recommendations by the Spanish Society of Rheumatology on Fibromyalgia. Part 1: Diagnosis and treatment.
46. Recommendations by the Spanish Society of Rheumatology on the Management of Patients with Fibromyalgia. Part II.
47. Recommendations by the Spanish Society of Rheumatology on Fibromyalgia. Part 1: Diagnosis and Treatment.
48. Platypnea-orthodeoxia syndrome.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.